Humacyte Inc
About
Humacyte Inc (NASDAQ:HUMA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 27 2026
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026
Apr 24 2026
Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
Apr 22 2026
Humacyte Appoints Jim Mercadante as Chief Commercial Officer
Apr 21 2026
Humacyte Announces Israeli Ministry of Health Acceptance of Marketing Authorization Application for Symvess® for Vascular Trauma Repair
Mar 27 2026
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
Recent Videos
HUMA Stock (Humacyte stock analysis) HUMA STOCK PREDICTION & analysis & news today
Apr 21, 2026
HUMA Stock (Humacyte stock analysis) HUMA STOCK PREDICTION & analysis & news today
Apr 19, 2026
HUMA Stock Analysis | Humacyte, Inc. | April 13, 2026
Apr 11, 2026
HUMA Stock Analysis | Humacyte, Inc. | April 10, 2026
Apr 10, 2026
Financials
Revenue
$2.04 M
Market Cap
$142.63 M
EPS
-0.26